The decision is expected to facilitate timely access to Bavarian Nordic’s Imvanex
Category: News
Innovative immunotherapy drug HTL0039732 shows potential in trials
New study highlights potential benefits of menopausal hormone therapy
Promising results for novel orexin agonist in sleep-deprived volunteers
Patients with relapsed multiple myeloma gain access to life-extending therapy
New evidence highlights AI’s potential in early lung cancer detection
Molecular imaging agent 99mTc-maraciclatide to aid in disease prognostication
Critically ill individuals will benefit from futuristic tech
Research suggests that LLMs could be used to support trainee doctors, nurses and GPs